Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Castro

Showing results (431-440 of 451) with videos related to

Pageof 46
Sort By:
Cancer Cell|November 20, 2020
Molecular Features of Cancers Exhibiting Exceptional Responses to TreatmentDavid A Wheeler, Naoko Takebe, Toshinori Hinoue, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2021
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)Olga P Nyssen, Dino Vaira, Ángeles Pérez Aísa, et al.
The Lancet. Respiratory Medicine|August 14, 2018
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysisMichäel Duruisseaux, Anna Martínez-Cardús, Maria E Calleja-Cervantes, et al.
Helicobacter|March 17, 2020
Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg)Olga P Nyssen, Ángeles Pérez-Aisa, Bojan Tepes, et al.
The American Journal of Gastroenterology|February 4, 2025
Probiotics Prescribed With Helicobacter pylori Eradication Therapy in Europe: Usage Pattern, Effectiveness, and Safety. Results From the European Registry on Helicobacter pylori Management (Hp-EuReg)Diego Casas Deza, Javier Alcedo, Miguel Lafuente, et al.
United European Gastroenterology Journal|December 5, 2023
Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori managementManuel Pabón-Carrasco, Alma Keco-Huerga, Manuel Castro-Fernández, et al.
Gut|January 2, 2023
Empirical rescue treatment of <i>Helicobacter pylori</i> infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on <i>H. pylori</i> management (Hp-EuReg)Diego Burgos-Santamaría, Olga P Nyssen, Antonio Gasbarrini, et al.
Antibiotics (Basel, Switzerland)|December 30, 2020
European Registry on <i>Helicobacter pylori</i> Management: Effectiveness of First and Second-Line Treatment in SpainMaría Caldas, Ángeles Pérez-Aisa, Manuel Castro-Fernández, et al.
The American Journal of Gastroenterology|April 12, 2021
Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg)Olga P Nyssen, Angeles Perez-Aisa, Bojan Tepes, et al.
Scientific Reports|November 2, 2023
Author Correction: Comparison of the management of Helicobacter pylori infection between the older and younger European populationsPaulius Jonaitis, Olga P Nyssen, Ilaria Maria Saracino, et al.
Pageof 46

Showing results (431-440 of 451) with videos related to

Sort By:
Pageof 46
Cancer Cell|November 20, 2020
Molecular Features of Cancers Exhibiting Exceptional Responses to TreatmentDavid A Wheeler, Naoko Takebe, Toshinori Hinoue, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2021
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)Olga P Nyssen, Dino Vaira, Ángeles Pérez Aísa, et al.
The Lancet. Respiratory Medicine|August 14, 2018
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysisMichäel Duruisseaux, Anna Martínez-Cardús, Maria E Calleja-Cervantes, et al.
Helicobacter|March 17, 2020
Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg)Olga P Nyssen, Ángeles Pérez-Aisa, Bojan Tepes, et al.
The American Journal of Gastroenterology|February 4, 2025
Probiotics Prescribed With Helicobacter pylori Eradication Therapy in Europe: Usage Pattern, Effectiveness, and Safety. Results From the European Registry on Helicobacter pylori Management (Hp-EuReg)Diego Casas Deza, Javier Alcedo, Miguel Lafuente, et al.
United European Gastroenterology Journal|December 5, 2023
Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori managementManuel Pabón-Carrasco, Alma Keco-Huerga, Manuel Castro-Fernández, et al.
Gut|January 2, 2023
Empirical rescue treatment of <i>Helicobacter pylori</i> infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on <i>H. pylori</i> management (Hp-EuReg)Diego Burgos-Santamaría, Olga P Nyssen, Antonio Gasbarrini, et al.
Antibiotics (Basel, Switzerland)|December 30, 2020
European Registry on <i>Helicobacter pylori</i> Management: Effectiveness of First and Second-Line Treatment in SpainMaría Caldas, Ángeles Pérez-Aisa, Manuel Castro-Fernández, et al.
The American Journal of Gastroenterology|April 12, 2021
Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg)Olga P Nyssen, Angeles Perez-Aisa, Bojan Tepes, et al.
Scientific Reports|November 2, 2023
Author Correction: Comparison of the management of Helicobacter pylori infection between the older and younger European populationsPaulius Jonaitis, Olga P Nyssen, Ilaria Maria Saracino, et al.
Pageof 46